Survey: ACA lowers uninsured ranks by 9.5 million
- As many as 43% of adults potentially eligible for coverage had visited the marketplaces by early June 2014, up from 24% in December. Of those, 51% selected a private plan or enrolled in Medicaid;
- By the beginning of June, 60% of adults with new coverage said they had used their plans to go to a doctor or hospital or fill a prescription. Of those, 62% said they would have not have been able to afford or access this care prior to getting their new insurance;
- More than half of adults (54%) with new coverage said their plan included all or some of the doctors they wanted. More than three of five adults with new coverage who found primary care doctors were able to get an appointment within two weeks; and
- 81 percent of those with new coverage were optimistic their insurance would improve their ability to get the care they need. And 58% of adults with new insurance said they were better off now than before they had their coverage.
No comments found
Report: Patients facing growing challenges accessing orphan drugs
- Since 1983, 7% more orphan drugs have been approved in the United States than in Europe, and 17% more were approved first in the United States than were approved first in Europe;
- There are fewer denials of orphan drug coverage by U.S. payers than by European payers; and
- While U.S. payers often require prior authorization as a condition of reimbursement, European health authorities employ more stringent conditions, such as on-label indication restrictions, step edits and coverage with evidence development.
No comments found
P&G rumored to be preparing a re-entry into the incontinence market
P&G's entry into this category confirms the growing need for these personal hygiene products. It also echoes the past decade of peer reviewed studies showing both urinary and bowel leakage as real, everyday health and wellness issues for tens of millions of women and men as young as 40. My company recently launched a product for the single largest unaddressed consumer need in the category: accidental bowel leakage (ABL). While there have been pads for urinary leakage and disposable briefs for heavier bowel leakage, there haven’t been any products for light ABL.This is surprising since numerous studies confirm ABL is the single biggest unmet need in the category globally. To learn more, visit: www.ABLinfo.org. Butterfly Body Liners are the first patented product to offer discreet protection for ABL. They are the only personal hygiene product which adheres gently to the skin. Many women tell us the launch of Butterfly is as important as the invention of tampons. Men tell us they are grateful to have not been left out of the conversation. Butterfly’s innovation was recently recognized with the nonwovens industry 2014 INDA Vision Award, as well as an Edison Award. Increased conversation, education and innovative product solutions will lead to increased care and better wellness.